BCV
SOPH icon

Banque Cantonale Vaudoise’s SOPHiA GENETICS SOPH Stock Holding History

Banque Cantonale Vaudoise’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,000
Closed -$55K – 991
2024
Q2 		$55K Buy
12,000
+9,000
+300% +$43.9K ﹤0.01% 783
2024
Q1 		$15K Sell
3,000
-5,900
-66% -$28.5K ﹤0.01% 911
2023
Q4 		$42K Hold
8,900
– – ﹤0.01% 830
2023
Q3 		$23K Sell
8,900
-1,000
-10% -$3.17K ﹤0.01% 1059
2023
Q2 		$43K Sell
9,900
-18,000
-65% -$81.4K ﹤0.01% 985
2023
Q1 		$139K Hold
27,900
– – 0.01% 791
2022
Q4 		$57K Buy
27,900
+8,000
+40% +$18K ﹤0.01% 936
2022
Q3 		$53K Hold
19,900
– – ﹤0.01% 979
2022
Q2 		$73K Buy
19,900
+3,000
+18% +$15.2K ﹤0.01% 937
2022
Q1 		$130K Buy
16,900
+6,900
+69% +$77.5K 0.01% 880
2021
Q4 		$141K Buy
+10,000
New +$147K 0.01% 900

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banque Cantonale Vaudoise's SOPH Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of SOPHiA GENETICS (SOPH) in Q3 2024, closing a stake of 12,000 shares — an estimated $55K sold.

Banque Cantonale Vaudoise first reported a position in SOPH in Q4 2021 and held it in 11 quarters. The position peaked at $141K in Q4 2021. 30 funds tracked by Wall St. Rank hold SOPH as of Q3 2024.

  • Banque Cantonale Vaudoise reported no remaining SOPHiA GENETICS position as of Q3 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 12,000 SOPHiA GENETICS shares in Q3 2024, an estimated $55K.
  • Banque Cantonale Vaudoise first reported a position in SOPHiA GENETICS in Q4 2021 and held it in 11 quarters.
  • Banque Cantonale Vaudoise's SOPHiA GENETICS position peaked at $141K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.